APREA
Aprea is a Swedish biotech company focusing on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53. The Company's lead program, APR-246, is a first-in-class small molecule drug candidate in clinical development. Aprea's main shareholder is KDev Investments AB, an investment vehicle owned by Karolinska Development AB (Nasdaq Stockholm: KDEV) and Rosetta Capital Ltd. Other shareholders include Östersjöstiftelsen, Praktikerinvest, and KCIF Co-Investment Fund KB.
APREA
Industry:
Biotechnology Health Care Medical Personal Health Pharmaceutical
Founded:
2003-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.aprea.com
Total Employee:
11+
Status:
Active
Contact:
+460850884504
Email Addresses:
[email protected]
Total Funding:
112.88 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Analytics LetsEncrypt WordPress Google Universal Analytics Apache Wordpress Plugins Nginx
Similar Organizations
Ryboquin
Ryboquin uses its expertise to turn under-developed intellectual property ideas into viable commercial realities.
Fore Biotherapeutics
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Vico Therapeutics
Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Mirzyme Therapeutics
MirZyme is an innovative company focused on the development of tailored therapeutics to prevent preeclampsia and fetal growth restriction.
MicuRx Pharmaceuticals
MicuRx discovers and develops novel antibiotics to prevent and treat drug-resistant bacterial infections.
metaLinear
metaLinear focuses on the identification and validation of new drug targets for difficult to treat bacterial infections.
myTomorrows
myTomorrows is a global platform that connects patients with unmet medical needs to treatments in development around the world.
MicroGen Biotech
MicroGen Biotech uses Nature's microbes to reduce toxins in crops while increasing crop yields and reducing pollutants in arable soil.
Abacus Health Products
Abacus Health Products is an over-the-counter (OTC) line of topical pain relieving products infused with cannabidiol (CBD).
Anergis
Anergis discovers and develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization.
Antidote.me
Antidote is a digital health company that accelerates and improves medical research by combining technologies, data, and business models.
Atelerix
Atelerix provides storage and transportation of human cells at room temperature to companies.
Adagio Medical
Adagio Medical is engaged in the research and development of treatments for cardiovascular diseases.
Amplyx Pharmaceuticals
Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems
Echo
Echo is a simplifying pharmacy, helping everyone get the medicine they need.
Biohaven Pharmaceutical
Biohaven is a biopharmaceutical company that develops drug candidates targeting neurological diseases.
BridgeBio Pharma
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Forendo Pharma
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.
Targovax
Targovax develops active immunotherapy in the form of cancer vaccines for application in post-operation treatments.
Wuxi Biortus Biosciences
Wuxi Biortus Biosciences is an innovation-driven contract research organization committed to high-quality R&D services in drug discovery.
Sarissa Biomedical
Sarissa is developing a range of minimally invasive, microelectrode electrochemical sensors for the measurement of the purines.
SelfDiagnostics
Selfdiagnostics is an Estonian/German company with the purpose of developing and marketing medical point-of-care (POC) diagnostics devices.
SiSaf
Delivering on the promise of RNA therapeutics
ShouTi
ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR.
Synapse Medicine
Synapse Medicine offers a medication intelligence platform for healthcare professionals.
SOM Biotech
Drug innovation company based on a pioneering AI-based drug discovery technology, that has built a robust pipeline for Orphan CNS diseases.
Sky Medical Technology
Sky Medical develops bioelectronic medicine to prevent and treat acute and chronic circulatory conditions.
Doctrina
Doctrina is an online platform that allows pharmaceutical companies to educate pharmacy employees using short product videos.
Daye
Daye creates category-defining products and services that set a new standard for medical research and scientific innovation.
Definigen
Definigen provides human cells to the drug discovery sector for use in lead optimization and toxicity programs.
Haodf.com
Haodf.com Provides Internet Medical Platforms.
IAG, Image Analysis Group
IAG, imaging expert company helps to accelerate novel drug development by using the right analytical tools and modern trial infrastructure.
Immunocore
Immunocore is a biotechnology company that specializes in the development of TCR bispecific immunotherapies.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Opterion Health
Opterion Health is focused to bring innovation to dialysis care and foster home dialysis to improve the quality of life for patients.
ZO Skin Health
ZO Skin Health, Inc. develops and delivers innovative skincare solutions that optimize skin health around the globe.
Capella BioScience
Capella Bioscience engages in the discovery and development of monoclonal antibodies.
Camurus
A pharmaceutical company specialising in developing innovative specialty medicines based in Lund
COMPASS Pathways
Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.
Calypso Biotech
Calypso Biotech's vision is to give new hope to patients suffering from severe gastro-intestinal diseases.
CerRx
CerRx engages in the discovery and development of anticancer drugs such as Fenretinide and Safingol.
Kuur Therapeutics
Kuur Therapeutics is committed to transforming the lives of patients with cancer & is leading the development cell therapies.
PACT Pharma
Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.
Prescient Healthcare Group
Prescient Healthcare Group was founded in London in 1995, originally specializing in competitive insights.
Peptomyc
Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.
Phagenesis
Phagenesis is engaged in the development of a device to treat dysphagia, a condition that disables the safe swallowing of food.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Phico Therapeutics
Phico Therapeutics is a developer of novel platform technology designed to overcome antibacterial resistance.
ptTheragnostic
ptTheragnostic focuses on the development of genomics-based personalized analysis for radiation sensitivity.
Peerwell
PeerWell covers the full continuum of musculoskeletal care — from pain & prevention through to complex surgery & recovery.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-05-16 | Atrin Pharmaceuticals | Atrin Pharmaceuticals acquired by Aprea | N/A |
Investors List
Janus Henderson Investors
Janus Henderson Investors investment in Series C - Aprea
Redmile Group
Redmile Group investment in Series C - Aprea
Karolinska
Karolinska investment in Series C - Aprea
Rock Springs Capital
Rock Springs Capital investment in Series C - Aprea
Sectoral Asset Management
Sectoral Asset Management investment in Series C - Aprea
Versant Ventures
Versant Ventures investment in Series C - Aprea
5AM Ventures
5AM Ventures investment in Series C - Aprea
HealthCap
HealthCap investment in Series C - Aprea
5AM Ventures
5AM Ventures investment in Series B - Aprea
Sectoral Asset Management
Sectoral Asset Management investment in Series B - Aprea
Official Site Inspections
http://www.aprea.com Semrush global rank: 6.27 M Semrush visits lastest month: 1.2 K
- Host name: 104.21.90.229
- IP address: 104.21.90.229
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
